De Barsy, syndrome
|
Very rare. Autosomal recessive transmission of mutations of the PYCR1 gene (17q25.3) (type B) that codes for pyrroline-5-carboxylate reductase, the ALDH18A1 (10q24.1) (type A or cutis laxa type 3) but mutation of the ATP6VOA2-CDG gene have been identified in some patients. Those mutations could lead to a fragmentation of mitochondrias and exacerbated apoptosis in case of oxidative stress.
Association of:
- intrauterine and later postnatal growth retardation
- skin hyperlaxity (cutis laxa) with very fragile skin (paper-like)
- progeroid aspect,
- corneal opacities with myopia and cataracts as well as glaucoma
- facial dysmorphism: downslanting palpebral fissures, broad nose with anteverted nares, small mouth
- mental retardation with hyperreflexia and athetoid movements
- ligamentar hyperlaxity that causes orthopedic deformities (congenital dislocation of the hip, pelvis, hands).
- progressive dilatation of the aortic arch
Anesthetic implications:
mental retardation; difficult venous access; thin and fragile skin; difficult mask ventilation and ventilation; low risk of hyperthermia (non-malignant) and intraoperative tachycardia; premature aging ?
References :
- Aponte EP, Smith HM, Wanek BJ, Rettke SR.
Anesthesia considerations for patients with de Barsy syndrome.
J Clin Anesth 2010 ; 22 :499-504
- Warner LL, Olsen DA, Smith HM.
Clinical implications of de Barsy syndrome.
Pediatr Anesth 2018; 28: 59-62.
Updated: December 2017